New hires and promotions in the biopharma industry in Asia-Pacific, including: Tessa Therapeutics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aridis, Athersys, Biontech, Calcimedica, Chimerix, Cromos, Eiger, Eli Lilly, Geneone Life Science, Gilead Sciences, Gracell, I-Mab, Innate, Innovent, Inovio, Janssen, Lupin, Mesoblast, Morphosys, Novartis, Pfizer, R-Pharm, Synairgen, Yuhan.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Akarx, Algernon, Ascentage, Capricor, Combioxin, Cytodyn, Junshi, Moderna, Pharmamar, Remegen, Shionogi, Telix.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Affibody, Alnylam, Anixa, Aravive, Astellas, Astrazeneca, Atreca, Bausch + Lomb, Beigene, Bioage Labs, Biocon, Bixink, Catalent, Celltrion, Clearside, Cytodyn, Daewoong, Edigene, Eli Lilly, Evergreenhealth, Fujifilm Diosynth, Generex, Gilead, Harbour, Heat Biologics, IGM Biosciences, Inovio, Insilico, J&J, Junshi, Lonza, Marinomed, Moderna, Mylan, Nanoviricides, Noachis Terra, Ology, Ontochem, Oragenics, Oxford Biodynamics, Pneumagen, Proteogenix, Puma, Recce, Sarepta, Secarna, Shionogi, Stabilitech, Taisho, Takis, Teva, Union, Vaxart, Verndari, Vir, Viralclear, Vistagen, Wuxi, Xbiotech USA, Xortx.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Pluristem.

Quarterly snapshots from biopharma companies with marketed products, including: Insmed.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bio-Rad, Euroimmun, Lifesignals, Nuvasive, Vitalconnect.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptive Biotechnologies, Alung Technologies, Applied DNA Sciences, Avidium Labs, Bayer, Ben-Gurion University, Biocardia, Biocat, Caredx, Cycle Pharmaceuticals, Invicro, Labcorp, Launchpad Medical, Medherant, Microsoft, Neogenomics, Nxt Group, Oberland Capital Management, Osang Healthcare, Proteus Digital Health, Resmed, Safeguard Medical, Sg Blocks, Spartan Bioscience, Stoltz One, Tangen Biosciences, Thinklabs, Water-Jel Technologies, Zoom+Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences.

Med-tech firms raising money in public or private financings, including: Defymed, Embody, Pulmonx.